AILINCOM 
SalusScientists have discovered a rare population of immune cells that play a crucial role in fighting tumors. Activating these cells could significantly enhance the effectiveness of modern cancer therapies.
CursusA new study has shown that inherited genetics influence not only the risk of developing cancer, but also how tumors form. These findings highlight the importance of a personalized approach to diagnosis and treatment.
SalusScientists have developed an experimental CRISPR-based technology that makes prostate tumors more susceptible to immune attack and increases the effectiveness of immunotherapy. This new approach could open up possibilities for treating other types of cancer that are difficult to manage with current therapies.
SalusStudies indicate that changing cancer therapy before a relapse occurs can improve treatment effectiveness and slow the development of tumor resistance. However, this approach requires further clinical validation.
SalusResearchers at KAIST have developed a method that allows macrophages to be reprogrammed directly within tumors, turning them into active cancer fighters. This approach could enhance the effectiveness of immunotherapy and simplify the treatment of complex types of tumors.
SalusScientists from Cambridge have developed an innovative two-component drug delivery system that is activated only in tumor tissues, minimizing side effects and increasing the safety of cancer immunotherapy.
SalusA new study has shown that impaired blood flow accelerates tumor growth by weakening the body's immune defenses, in a manner similar to aging. These findings pave the way for new strategies in cancer prevention and treatment.
SalusAmerican researchers have found that the use of injectable and oral medroxyprogesterone acetate increases the risk of meningioma, while combined oral contraceptives and IUDs, on the contrary, reduce this risk.